AAAAAA

   
Results: 1-20 |
Results: 20

Authors: MONNET I BRIENZA S HUGRET F VOISIN S GASTIABURU J SALTIEL JC SOULIE P ARMAND JP CVITKOVIC E DECREMOUX H
Citation: I. Monnet et al., PHASE-II STUDY OF OXALIPLATIN IN POOR-PROGNOSIS NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 34(7), 1998, pp. 1124-1127

Authors: BRAIN E SOULIE P DELALANDE B BERNARD A BANAL A MAHE E CVITKOVIC F ROUESSE J RAMBERT P
Citation: E. Brain et al., INTENSIFIED ALTERNATING CHEMOTHERAPY (CT) AND RADIOTHERAPY (RT) FOR STAGE-III-IV HEAD-AND-NECK-CANCER (HNC) PATIENTS (PTS), Annals of oncology, 9, 1998, pp. 365-365

Authors: DECREMOUX H BEKRADDA M MONNET I SOULIE P SALTIEL S MISSET JL FANDI A BENSMAINE MA CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 474-474

Authors: GERMANN N SOULIE P BRIENZA S ROTARSKY M EMILE JF DIPALMA M MUSSET M REYNES M CVITKOVIC E MISSET JL
Citation: N. Germann et al., OXALIPLATIN (LOHP) - A NEW PLATINUM ANALOG ACTIVE ON REFRACTORY RELAPSED NON-HODGKINS-LYMPHOMA/, Annals of oncology, 9, 1998, pp. 528-528

Authors: FUMOLEAU P TUBIANAHULIN M SOULIE P DELECROIX V SISTAC F MEFTI F SOULAS F APPIA F LEBECQ A VERGNIOL JC VERNILLET L RIVA A
Citation: P. Fumoleau et al., A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 387-387

Authors: DECREMOUX H BEKRADDA M MONNET I SOULIE P SALTIEL S MISSET JL FANDI A BENSMAINE MA CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 446-446

Authors: BEKRADDA M CHATELUT E CVITKOVIC E SOULIE P CANAL P MISSET JL DUPONTANDRE G BENSMAINE MA BUGAT R
Citation: M. Bekradda et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS OF THE CARBOPLATIN (CBDCA)OXALIPLATIN (L-OHP) COMBINATION IN PATIENTS (PTS) WITH ADVANCED MALIGNANCIES - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I TRIAL/, Annals of oncology, 9, 1998, pp. 447-447

Authors: BOURGEOIS H TURPIN F BOUCHADA M VOLTERS A CVITKOVIC F GOUPIL A JANVIER M TUBIANAHULIN M SOULIE P BERLIE J GIRARD M ROUESSE J
Citation: H. Bourgeois et al., MITOMYCIN-VINORELBINE AS 2ND LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, Bulletin du cancer, 85(9), 1998, pp. 794-798

Authors: SOULIE P BENSMAINE A GARRINO C CHOLLET P BRAIN E FERERES M JASMIN C MUSSET M MISSET JL CVITKOVIC E
Citation: P. Soulie et al., OXALIPLATIN CISPLATIN (L-OHP/CDDP) COMBINATION IN HEAVILY PRETREATED OVARIAN-CANCER/, European journal of cancer, 33(9), 1997, pp. 1400-1406

Authors: TRANDAFIR L RUFFIE P BOREL C MONNET I SOULIE P ADAMS D CVITKOVIC E ARMAND JP
Citation: L. Trandafir et al., HIGHER DOSES OF ALPHA-INTERFERON DO NOT INCREASE THE ACTIVITY OF THE WEEKLY CISPLATIN-INTERFERON COMBINATION IN ADVANCED MALIGNANT MESOTHELIOMA, European journal of cancer, 33(11), 1997, pp. 1900-1902

Authors: SOULIE P TRANDAFIR L TAAMMA A LOKIEC F BRAIN E DELORD JP MITA A VANNETZEL JM CVITKOVIC E MISSET JL
Citation: P. Soulie et al., SCHEDULE-DEPENDENT PACLITAXEL TOLERANCE ACTIVITY - DATA FROM A 7 DAY INFUSION PHASE-I STUDY WITH PHARMACOKINETICS IN PACLITAXEL REFRACTORY OVARIAN-CANCER/, Anti-cancer drugs, 8(8), 1997, pp. 763-766

Authors: FAIVRE S GOLDWASSER F SOULIE P MISSET JL
Citation: S. Faivre et al., PACLITAXEL (TAXOL(R))-ASSOCIATED JUNCTIONAL TACHYCARDIA, Anti-cancer drugs, 8(7), 1997, pp. 714-716

Authors: BRAIN ECG MITA A SOULIE P ERRIHANI H BESSARD ACH CHAOUCHE M ALEXANDRE J DELORD JP CVITKOVIC E JASMIN C MISSET JL
Citation: Ecg. Brain et al., 6-DAY CONTINUOUS-INFUSION OF HIGH-DOSE IFOSFAMIDE WITH BONE-MARROW GROWTH-FACTORS IN ADVANCED REFRACTORY MALIGNANCIES, Journal of cancer research and clinical oncology, 123(4), 1997, pp. 227-231

Authors: HALLE JC MOKHTARI M SOULIE P POUET MJ
Citation: Jc. Halle et al., EVALUATION OF THE ELECTRON-WITHDRAWING CH ARACTER OF THE 4-NITROBENZOFURAZANYL MOIETY - IONIZATION OF 7-ANILINO-4-NITROBENZOFURAZANS, Canadian journal of chemistry, 75(9), 1997, pp. 1240-1247

Authors: SOULIE P RAYMOND E BRIENZA S CVITKOVIC E
Citation: P. Soulie et al., OXALIPLATIN - THE FIRST DACH PLATINUM IN CLINICAL-PRACTICE, Bulletin du cancer, 84(6), 1997, pp. 665-673

Authors: SOULIE P RUFFIE P TRANDAFIR L MONNET I TARDIVON A TERRIER P CVITKOVIC E LECHEVALIER T ARMAND JP
Citation: P. Soulie et al., COMBINED SYSTEMIC CHEMOIMMUNOTHERAPY IN ADVANCED DIFFUSE MALIGNANT MESOTHELIOMA - REPORT OF A PHASE I-II STUDY OF WEEKLY CISPLATIN INTERFERON ALFA-2A, Journal of clinical oncology, 14(3), 1996, pp. 878-885

Authors: FARHAT F CULINE S LHOMME C DUVILLARD P SOULIE P MICHEL G TERRIERLACOMBE MJ THEODORE C SCHREINEROVA M DROZ JP
Citation: F. Farhat et al., DESMOPLASTIC SMALL ROUND-CELL TUMORS - RESULTS OF A 4-DRUG CHEMOTHERAPY REGIMEN IN 5 ADULT PATIENTS, Cancer, 77(7), 1996, pp. 1363-1366

Authors: FARHAT F CULINE S LHOMME C DUVILLARD P TERRIERLACOMBE MJ MICHEL G SOULIE P THEODORE C LOTZ JP DROZ JP
Citation: F. Farhat et al., ADULT DESMOPLASTIC SMALL ROUND-CELL TUMOR S - A NEW ENTITY, Bulletin du cancer, 82(8), 1995, pp. 665-673

Authors: LLORY JF SOULIE P CVITKOVIC E MISSET JL
Citation: Jf. Llory et al., FEASIBILITY OF HIGH-DOSE PLATINUM DELIVERY WITH COMBINED CARBOPLATIN AND OXALIPLATIN, Journal of the National Cancer Institute, 86(14), 1994, pp. 1098-1099

Authors: DEFORNI M GUALANO V CANAL P MARTEL P IZARSOUM F CHEVREAU C SOULIE P ROCHE H BUGAT R
Citation: M. Deforni et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL BY DOUBLE ROUTE (INTRAVENOUS AND INTRAPERITONEAL) WITH MODULATION BY FOLINIC ACID - CLINICAL AND PHARMACOKINETIC, PHASE-I STUDY IN PATIENTS WITH INTRAABDOMINAL MALIGNANCIES, Bulletin du cancer, 80(5), 1993, pp. 408-417
Risultati: 1-20 |